Literature DB >> 3933029

Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.

S A Checkley, C Thompson, S Burton, C Franey, J Arendt.   

Abstract

In six normal male subjects the mydriatic effect of tyramine eye drops was inhibited by 1 day's treatment with desipramine and the (+)- but not the (-)-enantiomer of oxaprotiline. In the same experiment, the secretion of melatonin was increased after treatment with (+)- but not with (-)-oxaprotiline. The effects of (+)-oxaprotiline and of desipramine treatment were similar, as were those of (-)-oxaprotiline and placebo. These findings extend to clinical studies the demonstration in animal experiments of stereo-specificity for the effects of (+)- and (-)-oxaprotiline upon noradrenaline uptake. A comparison of the effects of the two enantiomers should provide an ideal strategy for studying effects of noradrenaline uptake blockade in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933029     DOI: 10.1007/bf00431790

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain.

Authors:  D C U'Prichard; D A Greenberg; P P Sheehan; S H Snyder
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

Review 2.  Neural control of pineal function in mammals and birds.

Authors:  R Y Moore
Journal:  J Neural Transm Suppl       Date:  1978

3.  The effects of alaproclate on the pupillary responses to tyramine, phenylephrine and pilocarpine in depressed patients.

Authors:  C Thompson; S A Checkley
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Direct radioimmunoassay for melatonin in plasma.

Authors:  S Fraser; P Cowen; M Franklin; C Franey; J Arendt
Journal:  Clin Chem       Date:  1983-02       Impact factor: 8.327

5.  Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer.

Authors:  P C Waldmeier; P A Baumann; K Hauser; L Maitre; A Storni
Journal:  Biochem Pharmacol       Date:  1982-06-15       Impact factor: 5.858

6.  Brain histamine receptors as targets for antidepressant drugs.

Authors:  P D Kanof; P Greengard
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

7.  Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A.

Authors:  P C Waldmeier; P A Baumann; M Wilhelm; R Bernasconi; L Maître
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432

8.  Growth hormone and other responses to clonidine in patients with endogenous depression.

Authors:  S A Checkley; A P Slade; E Shur
Journal:  Br J Psychiatry       Date:  1981-01       Impact factor: 9.319

9.  Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness.

Authors:  K Ghose; A Coppen; P Turner
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

10.  MELATONIN SYNTHESIS IN THE PINEAL GLAND: CONTROL BY LIGHT.

Authors:  R J WURTMAN; J AXELROD; L S PHILLIPS
Journal:  Science       Date:  1963-11-22       Impact factor: 47.728

View more
  7 in total

1.  An alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man.

Authors:  E Palazidou; A Papadopoulos; A Sitsen; S Stahl; S Checkley
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Some central pharmacological effects of (+)- and (-)-oxaprotiline.

Authors:  J Maj; Z Rogóź; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Oxaprotiline enantiomers stimulate ACTH and corticosterone secretion in the rat.

Authors:  E Przegaliński; B Budziszewska; A Grochmal
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors.

Authors:  J Maj; K Wedzony; V Klimek; Z Rogóz; G Skuz
Journal:  J Neural Transm Gen Sect       Date:  1990

5.  Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

Authors:  D J Skene; C J Bojkowski; J Arendt
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

6.  Acute treatment with desipramine stimulates melatonin and 6-sulphatoxy melatonin production in man.

Authors:  C Franey; M Aldhous; S Burton; S Checkley; J Arendt
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

7.  Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.

Authors:  S H Kennedy; B A Davis; G M Brown; C G Ford; J d'Souza
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.